Medicinova (MNOV) Net Cash Flow (2010 - 2025)

Medicinova (MNOV) has 16 years of Net Cash Flow data on file, last reported at -$2.0 million in Q4 2025.

• On a quarterly basis, Net Cash Flow fell 4.4% year-over-year to -$2.0 million in Q4 2025; TTM through Dec 2025 was -$9.8 million, a 7.82% increase from a year earlier, with the FY2025 full-year figure at -$9.6 million, up 10.1% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$2.0 million, down from -$1.7 million in the prior quarter.
• Over the last five years, Net Cash Flow for MNOV reached as high as $36.8 million in Q1 2023 and fell as low as -$34.0 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$974964.4 across 5 years, with a median of -$2.4 million in 2023.
• Across the five-year window, Net Cash Flow plunged 844.71% in 2022 and surged 1085.72% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at -$3.6 million in 2021, then plunged by 844.71% to -$34.0 million in 2022, then soared by 98.53% to -$499038.0 in 2023, then slumped by 287.09% to -$1.9 million in 2024, then dropped by 4.4% to -$2.0 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$2.0 million in Q4 2025, -$1.7 million in Q3 2025, and -$2.3 million in Q2 2025.